Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 07/20/16
End: 03/30/17
Due: 03/30/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb) | NCT02598128 | Alcresta Therapeutics, Inc. | user2@example.com | None | 2015-11-30 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |
| Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study | NCT02750501 | Alcresta Therapeutics, Inc. | user2@example.com | None | 2016-07-20 | 2017-03-30 | 2018-03-30 | - | - | 2025-07-14 |